11 results
Appearance of Liver Lesions on Various Imaging Modalities
 • Computed Tomography (CT) - Arterial Phase, Portal
Appearance of Liver Lesions ... Contrast #CT #MRI #POCUS ... #radiology #differential ... diagnosis #comparison #table ... #appearance #hepatology
Appearance of Liver Lesions on Computed Tomography (CT) - Arterial Phase, Portal Venous Phase and Delayed
Appearance of Liver Lesions ... Arterial Phase, Portal ... #CT #radiology ... diagnosis #comparison #table ... #appearance #hepatology
Appearance of Liver Lesions on Contrast Enhanced Ultrasound - Early arterial, Grayscale phase, Late arterial phase,
arterial phase, Portal ... #Contrast #POCUS ... #radiology #differential ... diagnosis #comparison #table ... #appearance #hepatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral ... direct-acting oral ... molecular weight heparin ... Anticoagulation #Management #Hematology ... #Oncology
Purpura - Differential Diagnosis Framework

Non-blanchable, dark red to purple, hemorrhagic skin lesions that result from leakage
hemorrhagic skin lesions ... Decreased Support Of Dermal ... Cholesterol emboli • Septic ... Differential #Diagnosis #hematology ... #rheumatology #
Appearance of Liver Lesions on Magnetic Resonance Imaging (MRI) - T2, T1 precontrast, T1 portal venous,
Appearance of Liver Lesions ... #Hepatic #MRI # ... MagneticResonance #radiology ... diagnosis #comparison #table ... #appearance #hepatology
Venous Thrombosis vs Arterial Thrombosis - Differential Diagnosis Framework

VENOUS THROMBOSIS

 • Acquired Risk Factors:
	- >48 hours
• Drugs: - Oral ... atherosclerotic lesions ... cardiac valves (septic ... Hyperhomocysteinemia - Heparin-induced ... pathophysiology #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
DOAC, direct oral ... low-molecular-weight heparin ... Anticoagulation #Management #Hematology ... #Oncology
Monoclonal Gammopathy of Undetermined Significance (MGUS) - Summary Framework

Hematologic disorder characterized by the presence of either
Summary Framework Hematologic ... sub-types based on the hematologic ... Anemia, and Bone lesions ... #Significance #hematology ... #diagnosis #oncology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
: - Genetic lesions ... syndrome (MDS) (normal ... megakaryocytes and a normal ... Aplastic #Anemia #oncology ... #hematology #diagnosis